Drug-drug interactions via mechanism-based cytochrome P450 inactivation: points to consider for risk assessment from in vitro data and clinical pharmacologic evaluation.
Curr Drug Metab. 2007 Jun;8(5):449-62. doi: 10.2174/138920007780866861.
Curr Drug Metab. 2007.
PMID: 17584016